POLYCYCLIC QUINAZOLINES, PREPARATION THEREOF, AND USE THEREOF
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Nov 24, 2011
app pub date -
May 20, 2011
filing date -
May 21, 2010
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
At least one active pharmaceutical ingredient is chosen from polycyclic quinazolines of formula V,pharmaceutically acceptable salts thereof, and hydrates of the pharmaceutically acceptable salts. The active pharmaceutical ingredients disclosed may be inhibitors of protein tyrosine kinase inhibitors and/or aurora kinase. The active pharmaceutical ingredients can be used for treating cancers susceptible to treatment with protein tyrosine kinase inhibitors and/or aurora kinase inhibitors.
First Claim
Other Claims data not available